Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
Provided By PR Newswire
Last update: Oct 18, 2022
Proposed acquisition will accelerate gene therapies that aim to restore, improve, and preserve hearing for patients living with disabling hearing loss worldwide
Read more at prnewswire.com873.68
+0.56 (+0.06%)
Find more stocks in the Stock Screener
LLY Latest News and Analysis
17 days ago - ChartmillMarket Monitor February 6thMarket Recap: Wall Street Gains, Amazon Slips, and U.S. Job Growth Slows
